Cardiovascular disease (CVD) associated with COVID-19 is likely a consequence of the dysregulation of the ACE/ACE2 system, first due to SARS-CoV-2 infection but exacerbated by comorbidities such as hypertension [9], [10], [11]. This evidence concerns the gene ACE2 and COVID-19.